Skip to main content
Filing year 2024

NORMALEAH OVARIAN CANCER INITIATIVE

Bettendorf, Iowa·EIN 26-2976159·NTEE H30 · Medical Research·501(c)(3)
Total revenue
$110k
Total assets
$97k
Total expenses
$97k
Reported officers
11

Executive compensation

Form 990-EZ · Part IV · 1 reported individual · Filing year 2024

Percentile bands compare each position's total pay with the same role at Medical Research organizations nationwide.

Executive Director
10th to 25th percentile
$30k
$32k

Teal figures restate each filed amount in 2026 dollars.

Estimated with BLS CPI-U for the Midwest region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Plus 10 unpaid individuals.

Browse compensation in Medical Research

Pay in context

Top pay as a share of expenses

In 2024, the highest total compensation at NORMALEAH OVARIAN CANCER INITIATIVE equaled 31% of the organization's total expenses. The median for medical research organizations is 10%.

This organization (2024)
31%
Sector median
10%
Middle half of sector
4% to 21%

Based on 1,118 medical research organizations, each measured at its most recent filing year with reported expenses and compensation.

Funded by

Private foundations whose Form 990-PF Part XV grants matched this organization.

Financial trend

Revenue and expenses over time

NORMALEAH OVARIAN CANCER INITIATIVE reported revenue and expenses across 2 filing years.

RevenueExpenses
$96k
$108k
2023
$110k
$97k
2024
Total revenue and total expenses from IRS Form 990 filings.
Sector benchmark

What Medical Research executives earn

Comparable medical research organizations nationwide pay their highest-earning executive a median of $120,264.

25th percentile
$48k
Median
$120,264
75th percentile
$252k
90th percentile
$466k

These are medical research sector-wide figures, not this organization's reported pay. Based on 1,118 organizations across 1,118 filings (2020 – 2024).

See full Medical Research compensation data
FAQ

Common questions about NORMALEAH OVARIAN CANCER INITIATIVE

What does the Chief Executive Officer of NORMALEAH OVARIAN CANCER INITIATIVE earn?

In 2024, the Chief Executive Officer of NORMALEAH OVARIAN CANCER INITIATIVE received $30,077 in total compensation. This pay is in the bottom quarter for Chief Executive Officer roles among Medical Research organizations nationwide, above the lowest 10% of comparable filings. Based on IRS Form 990 data.

How does Chief Executive Officer pay at NORMALEAH OVARIAN CANCER INITIATIVE compare with similar nonprofits?

Compared with the same role at Medical Research organizations nationwide, the 2024 pay of the Chief Executive Officer at NORMALEAH OVARIAN CANCER INITIATIVE falls between the 10th and 25th percentiles. In 2024, the highest total compensation at NORMALEAH OVARIAN CANCER INITIATIVE equaled 31% of the organization's total expenses. The median for medical research organizations is 10%.

What are NORMALEAH OVARIAN CANCER INITIATIVE's revenue and expenses?

In 2024, NORMALEAH OVARIAN CANCER INITIATIVE reported $110k in total revenue and $97k in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.